Researching Economical Adjuvants to Cancer Therapy
Part of paid clinical trials in Tallahassee, Florida.
- Sponsor
- Florida State University
- Study ID
- NCT07305259
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- Beta-glucan — DIETARY_SUPPLEMENT375mg of beta-glucan in the form of a ground mushroom powder. The supplement is provided in capsule form.
- Placebo — DIETARY_SUPPLEMENT375mg of microcrystalline cellulose in capsule form.
Study Details
The goal of this clinical trial is to learn if beta-glucan (a dietary fiber) improves the function of the immune system in adults. It will also tell the investigators if combining beta-glucan with single bouts of exercise provides additional benefit. The main questions it aims to answer are: 1. Does beta-glucan change the ability of immune cells to recognize cancer cells? 2. Does exercise change the type of immune cells in the blood? Researchers will compare beta-glucan to a placebo (a look-alike substance with no effect) to see if beta-glucan could improve immune function against cancer. Participants will: 1. Take beta-glucan or a placebo daily for 4 weeks. 2. Visit the laboratory for three exercise tests. 3. Provide blood samples so researchers can study immune system cells.
Key Dates
- Start date
- Nov 12, 2025
- Status verified
- Dec 2025
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Beta-glucan375mg of beta-glucan is provided daily for 4 weeks.
- Placebo Comparator: Placebo375mg of cellulose daily for 4 weeks.
Primary Outcome Measure
Cellular Cytotoxicity Assessed With Flow Cytometry [ Time Frame: At baseline, the end of treatment at four weeks, and at eight weeks after a washout phase. ]
Central Contacts
- Kyle A Smith, PhD, RD850-644-1016
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Institute of Sports Sciences and Medicine | Tallahassee | Florida | 32306 | Kyle A Smith, PhD, RD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Tallahassee, FL
Related Studies
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaPHASE1 · Recruiting · AstraZeneca · Glendale, California
- A Study to Learn About a Vaccine Against E Coli in Healthy AdultsPHASE1 · Recruiting · Pfizer · Anaheim, California
- The Increasing Mindfulness Engagement ProjectRecruiting · Florida State University · Tallahassee, Florida